Magnolia compressa
Magnolia compressa · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Magnolia compressa is a botanical species that has garnered significant attention within the field of medicinal pharmacology. Researchers have identified the specific chemical compound micheliolide as a primary bioactive constituent within this plant. Scientific investigations are currently exploring how this substance interacts with complex cellular pathways. Specifically, studies are focusing on its potential therapeutic efficacy in treating Acute Myelogenous Leukemia. Understanding these chemical properties may eventually lead to new advancements in oncological treatments.
- Synonyms
- Michelia Formosana · Michelia Compressa Var. Angustifolia · 10 more
- Common names
- Not available
- Family
- Magnoliaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Magnolia compressa is a versatile species recognized by a wide array of regional names across different cultures. In many English-speaking botanical circles, it is commonly referred to as the Formosan michelia. It also holds the distinct name of kultanuppu magnolia in certain linguistic contexts. Moving to East Asia, the plant is known as オガタマノキ or タイワンオガタマノキ in Japan. Finally, in Chinese-speaking regions, it is identified by the name 烏心石.
Sources: Catalogue of Life (COL)
Synonyms
Magnolia compressa is a species that has been classified under several different botanical names throughout history. It is recognized by various synonyms, including the varieties Magnolia compressa var. formosana and Magnolia compressa var. lanyuensis. Taxonomic discussions also link the plant to the name Magnolia formosana. Furthermore, it has been previously identified within the genus Michelia as Michelia compressa. This complex naming history even extends to the specific form Michelia compressa f. angustifolia.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Magnolia compressa belongs to the vast kingdom Plantae, representing a significant part of the natural world. Within this kingdom, it is classified under the class Equisetopsida. The plant is further organized into the order Magnoliales, which defines its evolutionary lineage. It falls under the specific family Magnoliaceae, a group known for its distinctive floral structures. Ultimately, this species is a member of the well-recognized genus Magnolia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Magnoliales |
| Family | Magnoliaceae |
| Genus | Magnolia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Magnolia compressa is a species primarily distributed throughout the Asia-Temperate regions. Its natural range extends across diverse landscapes in China, specifically within the South-Central provinces. The plant is also widely established in Eastern Asia, making appearances in Japan and Korea. Furthermore, its presence can be found in the Nansei-shoto islands and throughout Taiwan. This broad geographic spread highlights the plant's significant ecological footprint across East Asian territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Magnolia compressa is a self-supporting species characterized by its distinct tree growth form. This robust plant can reach a maximum height of 17 meters as it matures. Its structural stability allows it to stand firmly within its natural environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Magnolia compressa serves as a natural source for the discovery of micheliolide, a potent guaianolide sesquiterpene lactone. This specific compound has demonstrated significant potential in combating acute myelogenous leukemia by targeting resistant stem cells. Research indicates that micheliolide exerts its cytotoxic effects by inhibiting NF-κB expression and generating intracellular reactive oxygen species. Such mechanisms allow the substance to effectively address the self-renewal capabilities that typically lead to cancer relapse. Consequently, these findings offer a promising foundation for developing new preclinical therapies derived from this plant.
Conditions
Magnolia compressa contains micheliolide, a natural compound that exhibits significant anticancer activity through the modulation of various signaling cascades. This specific substance has demonstrated the ability to treat acute myelogenous leukemia by exerting selective cytotoxic effects on leukemic stem cells. Research indicates that it can prolong the lifespan in mouse models of human acute myelogenous leukemia by inhibiting NF-κB expression. Furthermore, the anticancer potential of this plant constituent is supported by its ability to induce apoptosis and arrest the cell cycle across many cancer cell lines. These medicinal properties suggest that micheliolide derived from the plant could be developed into a novel therapeutic agent for treating malignancy.